rethinkTHC Search
Menu
Study breakdown

Clinical guideline recommends avoiding cannabis during pregnancy and breastfeeding

ReviewModerate evidence
The takeaway

A Canadian clinical guideline concluded cannabis use during pregnancy and breastfeeding should be avoided given limited safety data, while emphasizing screening, supportive communication, and harm reduction if abstaining is not feasible.

Obstetricians, midwives, and healthcare providers caring for women of reproductive age.

Recommends avoidance or maximum reduction if abstaining not feasible

What the researchers found

Based on GRADE-assessed evidence, the guideline recommends avoiding cannabis during pregnancy and breastfeeding, or reducing use as much as possible if abstaining is not feasible. Key focus areas include screening, dependence and withdrawal management, communication approaches, maternal/fetal outcomes, pain control, postpartum care including secondhand smoke, and breastfeeding considerations.

Why it matters

Cannabis use during pregnancy is increasing. Clinicians need evidence-based guidelines to counsel patients, particularly as social acceptability of cannabis grows.

The numbers in context

Literature search covered January 2018 to February 2021. Guideline addresses screening, dependence, withdrawal, communication, maternal/fetal outcomes, pain control, postpartum care, and breastfeeding.

How the study worked

Clinical practice guideline searching PubMed and Cochrane for articles published January 2018 to February 2021. Included clinical trials, observational studies, reviews, and guidelines on cannabis during pregnancy and breastfeeding. Evidence quality rated using GRADE.

What this study cannot tell us

Limited high-quality evidence available. Most studies are observational with potential confounders. Long-term follow-up data on cannabis-exposed pregnancies is sparse.

How to read the evidence

GRADE-assessed clinical guideline, but underlying evidence is largely observational with limited long-term data.

When this study was published

Published in 2022 with literature through February 2021.

The bigger picture

The guideline takes a harm reduction approach: rather than simply advising against use, it provides strategies for reducing harm when complete abstinence is not achievable.

Questions still open

  • What are the specific dose-response relationships between cannabis exposure during pregnancy and fetal outcomes? Are some formulations or routes of administration less harmful?

Common questions

Should cannabis be completely avoided during pregnancy?
The guideline recommends avoidance based on limited safety data. If abstaining is not feasible, reducing use as much as possible is recommended as a harm reduction approach.
What about cannabis and breastfeeding?
The guideline also recommends avoiding cannabis during breastfeeding, given the absence of safety data on long-term effects of cannabis exposure through breast milk.

Read the original research

Guideline No. 425b: Cannabis Use Throughout Women's Lifespans - Part 2: Pregnancy, the Postnatal Period, and Breastfeeding.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 44(4), 436-444.e1

Citation

Graves, Lisa E; Robert, Magali; Allen, Victoria M; Dama, Sumeet; Gabrys, Robert L; Tanguay, Robert L; Turner, Suzanne D; Green, Courtney R; Cook, Jocelynn L. (2022). Guideline No. 425b: Cannabis Use Throughout Women's Lifespans - Part 2: Pregnancy, the Postnatal Period, and Breastfeeding.. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 44(4), 436-444.e1. https://doi.org/10.1016/j.jogc.2022.01.013

Explore the wider topic